Back to results
US 6,649,184 B2Granted
Device and method for treating ophthalmic diseases
AssigneeNeurotech S.A.
InventorsJoseph P. Hammang, E. Edward Baetge, William G. Tsiarias, Peter D. Spear
Life of this patent
Estimating the term…
Abstract
The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.
Claims3
A method for delivering a biologically active molecule to the eye comprising:
- implanting a capsule periocularly, the capsule comprising a core containing a cellular source of the biologically active molecule and a surrounding biocompatible jacket, the jacket permitting diffusion of the biologically active molecule into the eye, wherein one or more second biologically active molecule is co-delivered to the eye, wherein the one or more second biologically active molecule is selected from the group consisting of anti-angiogenic factors, anti-inflammatory factors, factors retarding cell degeneration, factors promoting cell sparing, and factors promoting cell growth.
Dependencies are inferred from the claim text.